Proteomic Profiling Reveals Differential Mechanisms of Icariin and Epimedin C in Regulating Thymic Immunity

Authors

  • Haixin Wang Pharmaceutical College, Zhejiang Chinese Medical University, 310053 Hangzhou, Zhejiang, China Author
  • Bingqian He Academy of Chinese Medical Science, Zhejiang Chinese Medical University, 310053 Hangzhou, Zhejiang, China Author

DOI:

https://doi.org/10.62767/jecacm701.0515

Keywords:

icariin, epimedin C, proteomics, thymus, immunomodulation, divergent mechanisms

Abstract

Objective: To systematically compare the differential targets and molecular mechanisms of two active flavonoids from Epimedium, Icariin and Epimedin C, in the thymus using proteomics, and to elucidate the material basis for their immunomodulatory effects. Methods: BALB/c mice were randomly divided into Normal, Epimedin C, and Icariin groups. After 3 days of intraperitoneal administration, thymus tissues were collected for Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Bioinformatics methods were employed to screen differentially expressed proteins, followed by protein-protein interaction networks construction, and Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. Results: Epimedin C and Icariin regulated 62 and 103 differentially expressed proteins, respectively, with 21 common targets. Through network analysis, Superoxide dismutase 2 (Sod2) and Serine/arginine-rich splicing factor 1 (Srsf1) were identified as the shared core common targets. Functional enrichment analyses results revealed that both Sod2 and Srsf1 significantly affected mRNA splicing and mitochondrial energy metabolism pathways. However, Epimedin C uniquely regulated amino acid biosynthesis and the citric acid cycle (TCA cycle), whereas Icariin was more involved in SNARE interactions in vesicular transport and the JAK-STAT signaling pathway. Conclusions: Icariin and Epimedin C collectively maintain mRNA splicing homeostasis through their shared targets, Sod2 and Srsf1. However, due to structural differences, the two tend to regulate thymocyte reprogramming and signal transduction in distinct ways. Ligustrazine and caosetide C ultimately exert their immunomodulatory functions through synergistic and complementary effects on multiple targets and pathways.

References

Liu Z, Liang Q, Ren Y, et al. Immunosenescence: molecular mechanisms and diseases. Signal Transduction and Targeted Therapy 2023; 8(1): 200.

Yang X, Stedra J, Cerny J. Relative contribution of T and B cells to hypermutation and selection of the antibody repertoire in germinal centers of aged mice. Journal of Experimental Medicine 1996; 183(3): 959-970.

Wang M. Research progress on immunosenescence and cells of the innate immune system. Basic & Clinical Medicine 2016; 36(01): 125-129.

Shi JF, Gu GH, Zhang XG. Immune aging and its immunological warning indicators. Current Immunology 2005; 25(4): 347-349.

Fulop T, Dupuis G, Witkowski JM, et al. The Role of Immunosenescence in the Development of Age-Related Diseases. Revista Investige Clínica 2016; 68(2) :84-91.

Lynch HE, Goldberg GL, Chidgey A, et al. Thymic involution and immune reconstitution. Trends in Immunology 2009; 30(7): 366-373.

Palmer DB. The effect of age on thymic function. Frontiers in Immunology 2013; 4: 316.

Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nature Immunology 2013; 14(5): 428-436.

Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China, 1st ed; China Medical Science Press: Beijing, China, 2020; p340.

Guo BJ, Xiao W, Lin N, et al. Research Progress on Chemical Components and Pharmacological Effects of Epimedium. China Journal of Chinese Materia Medica 2012; 37(19): 2853-2861.

Zhai YK, Guo XY, Ge BF, et al. Icaritin, an exogenous phytomolecule, enhances osteogenesis but not angiogenesis—an in vitro efficacy study. Planta Medica 2010; 76(6): 602-608.

Zhen X, Liu J, Ren Y. Recent advances in proteomic strategies for target identification of traditional chinese medicine. Journal of Pharmaceutical Analysis 2025; 101516.

Zhao M, Che Y, Gao Y, et al. Application of multi-omics in the study of traditional Chinese medicine. Frontiers in Pharmacology 2024; 15: 1431862.

Zonta E, Bittencourt D, Samaan S, et al. The RNA helicase DDX5/p68 is a key factor promoting c-fos expression at different levels from transcription to mRNA export. Nucleic Acids Research 2013; 41(1): 554-564.

Heideman MR, Lancini C, Proost N, et al. Sin3a-associated Hdac1 and Hdac2 are essential for hematopoietic stem cell homeostasis and contribute differentially to hematopoiesis. Haematologica 2014; 99(8): 1292-1303.

Ma P, Hao Y, Wang W, et al. AURKB activates EMT through PI3K/AKT signaling axis to promote ICC progression. Discover Oncology 2023; 14(1): 102.

Papavasiliou F, Jankovic M, Suh H, et al. The cytoplasmic domains of immunoglobulin (Ig) alpha and Ig beta can independently induce the precursor B cell transition and allelic exclusion. Journal of Experimental Medicine 1995; 182(5): 1389-1394.

Dorris ER, O'Neill A, Treacy A, et al. The transcription factor CUX1 negatively regulates invasion in castrate resistant prostate cancer. Oncotarget 2020; 11(9): 846-857.

Fujii T, Komatsu Y, Yasoda A, et al. Circulating C-type natriuretic peptide (CNP) rescues chondrodysplastic CNP knockout mice from their impaired skeletal growth and early death. Endocrinology 2010; 151(9): 4381-4388.

Ma H, He X, Yang Y, et al. The genus Epimedium: an ethnopharmacological and phytochemical review. Journal of Ethnopharmacology 2011; 134(3): 519-541.

Liu R, Li A, Sun A, et al. Preparative isolation and purification of flavonoid glycosides from Epimedium brevicornum by high-speed counter-current chromatography. Journal of Chromatography A 2005; 1074(1-2): 111-115.

Wu H, Lien EJ, Lien LL. Chemical and pharmacological investigations of Epimedium species: a survey. Progress in Drug Research 2003; 60: 1-57.

Martinez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nature Communications 2020; 11(1): 102.

Gu A, Jie Y, Sun L, et al. New insights into the role of TGF-β in T cell immunity. Cellular & Molecular Immunology 2018; 15(5): 458-465.

Südhof TC, Rothman JE. Membrane fusion: grappling with SNARE and SM proteins. Science 2009; 323(5913): 474-477.

Villarino AV, Kanno Y, O'Shea JJ. Mechanisms and consequences of Jak-STAT signaling in the immune system. Nature Immunology 2017; 18(4): 374-384.

Tonelli C, Chio IIC, Tuveson DA. Transcriptional regulation by Nrf2. Antioxidants & Redox Signaling 2018; 29(17): 1727-1745.

Yang J, Park KW, Kim GE, et al. The oxidative metabolic profile of thymocyte development. Cell Reports 2021; 36(5): 109487.

Ankö ML, Neugebauer KM. Long noncoding RNAs add another layer to pre-mRNA splicing regulation. Molecular Cell 2010; 39(6): 833-834.

Inoue T, Shinnakasu R, Ise W, et al. The RNA-binding protein Mex3B regulates T cell receptor expression and T helper cell differentiation. The EMBO Journal 2018; 37(7): e97689.

Go YM, Jones DP. Redox control of splicing in cancer. Cancer Letters 2013; 332(2):229-233.

Wang YF, Chen NH. Research Progress on the Pharmacological Effects of Epimedin C. China Journal of Chinese Materia Medica 2020; 45(11): 2537-2543.

Downloads

Published

2026-03-27

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Issue

Section

Original Research

Similar Articles

1-10 of 12

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

<< < 1 2 3 4 5 6 7 8 9 10 > >>